Engineered protein cages for selective heparin encapsulation

Salla Välimäki, Qing Liu, Lise Schoonen, Daan F. M. Vervoort, Nonappa Nonappa, Veikko Linko, Roeland J. M. Nolte, Jan C. M. van Hest, Mauri Kostiainen

Research output: Contribution to journalArticleScientificpeer-review

81 Downloads (Pure)


A heparin-specific binding peptide was conjugated to a cowpea chlorotic mottle virus (CCMV) capsid protein, which was subsequently allowed to encapsulate heparin and form capsid-like protein cages. The encapsulation is specific and the capsid-heparin assemblies display negligible hemolytic activity, indicating proper blood compatibility and promising possibilities for heparin antidote applications.
Original languageEnglish
Pages (from-to)1272-1276
Number of pages5
JournalJournal of Materials Chemistry B
Issue number5
Publication statusPublished - 7 Feb 2021
MoE publication typeA1 Journal article-refereed


Dive into the research topics of 'Engineered protein cages for selective heparin encapsulation'. Together they form a unique fingerprint.

Cite this